A model-based approach to analyze the influence of UGT2B15

Therapeutic area :

Stringer F., Dejongh J., Scott G. and Danhof M., A model-based approach to analyze the influence of UGT2B15 polymorphism driven pharmacokinetic differences on the pharmacodynamic response of the PPAR agonist sipoglitazar, J Clin Pharmacol, 11(10): 227, 2013. [Link to publication]